[ad_1]
(MedPage Today) — The FDA approved an apomorphine hydrochloride infusion device (Onapgo) to treat motor fluctuations in adults with advanced Parkinson’s disease, Supernus Pharmaceuticals announced on Tuesday.
The wearable device is the first…
[ad_2]
Source link : https://www.medpagetoday.com/neurology/parkinsonsdisease/114074
Author :
Publish date : 2025-02-04 20:19:37
Copyright for syndicated content belongs to the linked Source.
FDA OKs New Wearable Treatment for Parkinson’s Disease
Related Posts
